The patent badge is an abbreviated version of the USPTO patent document. The patent badge does contain a link to the full patent document.
The patent badge is an abbreviated version of the USPTO patent document. The patent badge covers the following: Patent number, Date patent was issued, Date patent was filed, Title of the patent, Applicant, Inventor, Assignee, Attorney firm, Primary examiner, Assistant examiner, CPCs, and Abstract. The patent badge does contain a link to the full patent document (in Adobe Acrobat format, aka pdf). To download or print any patent click here.
Patent No.:
Date of Patent:
Jul. 28, 2026
Filed:
Oct. 14, 2025
Applicant:
Beyond Barriers Therapeutics, Inc., Glencoe, IL (US);
Inventors:
Ryan Kole, Glencoe, IL (US);
John Marshall, Glencoe, IL (US);
Charles Polsky, Glencoe, IL (US);
Brian Reinhardt, Glencoe, IL (US);
Thomas A. Degregoris, Glencoe, IL (US);
Assignee:
Beyond Barriers Therapeutics, Inc., Glencoe, IL (US);
Attorney:
Primary Examiner:
Int. Cl.
CPC ...
A61K 9/00 (2006.01); A61K 31/198 (2006.01); A61K 47/10 (2017.01); A61K 47/12 (2006.01); A61K 47/14 (2017.01); A61K 47/18 (2017.01); A61K 47/20 (2006.01); A61K 47/22 (2006.01); A61K 47/26 (2006.01); A61K 47/32 (2006.01); A61K 47/38 (2006.01); A61K 47/40 (2006.01); A61K 47/42 (2017.01);
U.S. Cl.
CPC ...
A61K 9/006 (2013.01); A61K 9/0056 (2013.01); A61K 31/198 (2013.01); A61K 47/10 (2013.01); A61K 47/12 (2013.01); A61K 47/14 (2013.01); A61K 47/183 (2013.01); A61K 47/20 (2013.01); A61K 47/22 (2013.01); A61K 47/26 (2013.01); A61K 47/32 (2013.01); A61K 47/38 (2013.01); A61K 47/40 (2013.01); A61K 47/42 (2013.01);
Abstract
Sublingual or buccal dosage forms comprise at least one antioxidant compound, such as N-acetyl cysteine (NAC), or a pharmaceutically acceptable salt thereof. The sublingual or buccal dosage forms are administered for treating central nervous system (CNS) disorders, such as traumatic brain injury or stroke.